Executive record

Matthew Szot

Matthew Szot holds the CFO seat at Stark Focus Group, Inc. on the record, Chief Financial Officer, effective October 8, 2026.

2 verified records · 2 companies · current seat on the record: Stark Focus Group, Inc.

Career line from the records

2

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-09-25TransitionStark Focus Group, Inc.current seat

    Stark Focus Group, Inc. CFO transition: Matthew Szot to succeed John Lipman

    Named as the incoming officer, Chief Financial Officer

    effective October 8, 2026 · 8-K filed September 25, 2026 · sec.gov, Item 5.02

  2. 2026-03-3110-K signatureCadrenal Therapeutics, Inc.

    Signed the annual report as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

    10-K filed March 31, 2026 · sec.gov

Companies

2

Stark Focus Group, Inc.

Cadrenal Therapeutics, Inc.CVKD

Pharmaceutical Preparations

This page lists only verified filing records that name Matthew Szot, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.